Results 11 to 20 of about 78,162 (300)

Bisphosphonate nephrotoxicity [PDF]

open access: yesKidney International, 2008
Bisphosphonates are valuable agents for the treatment of post-menopausal osteoporosis (PMO), hypercalcemia of malignancy, and osteolytic bone metastases. Oral bisphosphonates are used mainly to treat PMO and are not associated with significant nephrotoxicity.
Perazella, Mark A., Markowitz, Glen S.
openaire   +4 more sources

Retrospective Evaluation of Colistin Associated Nephrotoxicity at Oncology Hospital Intensive Care Unit

open access: yesTürk Yoğun Bakim Derneği Dergisi, 2014
Objective: The aim of our study, is to determine the nephrotoxicity rates and risk factors for the development of nephrotoxicity by retrospective evaluation of patients who were given colistin therapy oncology hospital intensive care unit.
Menşure Kaya   +6 more
doaj   +2 more sources

Experimental Cell Line Models for Nephrotoxicity Screening [PDF]

open access: yesРегуляторные исследования и экспертиза лекарственных средств, 2021
The aim of the study was to review literature data on cell models for experimental assessment of drug nephrotoxicity in vitro. Because of nephrotoxicity, 2% of new investigational medicinal products are discarded at the stage of preclinical in vivo ...
I. A. Mazerkina   +4 more
doaj   +2 more sources

Risk factors for calcineurin inhibitor nephrotoxicity after renal transplantation: a systematic review and meta-analysis

open access: yesDrug Design, Development and Therapy, 2018
Tianyi Xia, Sang Zhu, Yan Wen, Shouhong Gao, Mingming Li, Xia Tao, Feng Zhang, Wansheng Chen Department of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai, People’s Republic of China Background: Nephrotoxicity of ...
Xia T   +7 more
doaj   +1 more source

Human kidney organoids model the tacrolimus nephrotoxicity and elucidate the role of autophagy [PDF]

open access: yesThe Korean Journal of Internal Medicine, 2021
Background/Aims Tacrolimus has been used as an immunosuppressive agent in organ transplantation. Despite the therapeutic benefits, tacrolimus’s use is limited due to its nephrotoxicity.
Jin Won Kim   +12 more
doaj   +1 more source

Drug-Induced Nephrotoxicity: A Review [PDF]

open access: yesالمجلة العراقية للصيدلة, 2022
Background: Nephrotoxicity is referred to as rapid degeneration in kidney functioning due to the toxic effects of medications. The glomerulus and proximal renal tubule are the fundamental portions of the nephron to be affected by drugs leading to ...
Muthanna Khalaf, Zeina Althanoon
doaj   +1 more source

Sex Difference in Cisplatin-Induced Nephrotoxicity: Laboratory and Clinical Findings

open access: yesJournal of Toxicology, 2022
Cisplatin (CP) as the most important anticancer drug has limited usage due to a lot of side effects such as nephrotoxicity. Additionally, nephrotoxicity is gender/sex-related.
Fatemeh Eshraghi-Jazi, Mehdi Nematbakhsh
doaj   +1 more source

A Potentially Less Nephrotoxicity of Carboplatin Over Cisplatin as Radiosensitizer in Head-neck Cancer

open access: yesAsian Pacific Journal of Cancer Biology, 2022
Introduction: Head and neck cancers are the common cancers in developing countries, especially in Southeast Asia. Concurrent chemoradiation is the treatment of choice for locally advanced stage III to IVB squamous cell carcinoma of head and neck ...
Mahfujul Ahmed Riad
doaj   +1 more source

Mechanisms of calcineurin inhibitor nephrotoxicity in chronic allograft injury [PDF]

open access: yes, 2012
The first successful transplantation of a human kidney was performed more than 50 years ago by Murray and colleagues in 1954 between identical twins. The success of this transplantation was due to the fact that no significant rejection occurs between ...
Ryan, Michael P.   +4 more
core   +2 more sources

Comparison of Myelotoxicity and Nephrotoxicity Between Daily Low-Dose Cisplatin With Concurrent Radiation and Cyclic High-Dose Cisplatin in Non-Small Cell Lung Cancer Patients

open access: yesFrontiers in Pharmacology, 2020
AimAntineoplastic effect of cisplatin, the first line treatment in non-small cell lung cancer (NSCLC), is hindered by its nephrotoxicity and myelotoxicity. Both low-dose and high-dose regimens are used in the management of NSCLC. The aim of this study is
Zulfan Zazuli   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy